The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hsu Larry since 2009.
The trader's CIK number is 1245199.
At the time of the last reporting, Hsu Larry was the President and CEO of Impax Laboratories Inc. (stock ticker symbol IPXL).
Also see all insider trading activities at Impax Laboratories Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | IPXL | 0 | $0 | 0 | $0 | 73,500 | $694,795 |
| 2014 | IPXL | 0 | $0 | 373,186 | $10,065,539 | 53,000 | $660,210 |
| 2013 | IPXL | 7,000 | $118,125 | 0 | $0 | 75,000 | $228,000 |
| 2012 | IPXL | 0 | $0 | 0 | $0 | 180,000 | $1,243,800 |
| 2011 | IPXL | 10,000 | $190,000 | 0 | $0 | 0 | $0 |
| 2010 | IPXL | 15,000 | $237,300 | 0 | $0 | 50,000 | $250,000 |
| 2009 | IPXL | 150,000 | $645,329 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-25 | IPXL | Option Ex | 73,500 | 9.45 | 694,795 |
| 2014-09-30 | IPXL | Option Ex | 23,000 | 9.27 | 213,210 |
| 2014-09-09 | IPXL | Option Ex | 30,000 | 14.90 | 447,000 |
| 2014-06-05 | IPXL | Sale | 50,000 | 28.25 | 1,412,450 |
| 2014-06-06 | IPXL | Sale | 50,000 | 28.52 | 1,425,950 |
| 2014-05-22 | IPXL | Sale | 50,000 | 27.22 | 1,360,850 |
| 2014-05-21 | IPXL | Sale | 3,800 | 26.53 | 100,825 |
| 2014-05-06 | IPXL | Sale | 219,386 | 26.28 | 5,765,464 |
| 2013-03-12 | IPXL | Buy | 7,000 | 16.88 | 118,125 |
| 2013-01-18 | IPXL | Option Ex | 75,000 | 3.04 | 228,000 |
| 2012-01-11 | IPXL | Option Ex | 180,000 | 6.91 | 1,243,800 |
| 2011-08-16 | IPXL | Buy | 10,000 | 19.00 | 190,000 |
| 2010-08-12 | IPXL | Buy | 5,000 | 15.40 | 77,000 |
| 2010-08-11 | IPXL | Buy | 10,000 | 16.03 | 160,300 |
| 2010-08-03 | IPXL | Option Ex | 50,000 | 5.00 | 250,000 |
| 2009-01-27 | IPXL.OB | Buy | 50,000 | 5.00 | 250,000 |
| 2009-01-23 | IPXL | Buy | 12,900 | 3.80 | 49,020 |
| 2009-01-22 | IPXL | Buy | 87,100 | 3.98 | 346,309 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hsu Larry (President and CEO of Impax Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.